Primary Site >> Colorectal Cancer

Gene >> SRGN

Journal: Eur J Cancer. 1999 Nov;35(12):1735-42.
Title: Suppressive subtractive hybridisation reveals differential expression of serglycin, sorcin, bone marrow proteoglycan and prostate-tumour-inducing gene I (PTI-1) in drug-resistant and sensitive tumour cell lines of haematopoetic origin.
Author: Beyer-Sehlmeyer, G|Hiddemann, W|Wormann, B|Bertram, J
PMID: 10674022
Journal: Cell Cycle. 2011 Jul 15;10(14):2380-9.
Title: The relative contribution of pro-apoptotic p53-target genes in the triggering of apoptosis following DNA damage in vitro and in vivo.
Author: Kuribayashi, Kageaki|Finnberg, Niklas|Jeffers, John R|Zambetti, Gerard P|El-Deiry, Wafik S
PMID: 21709442
Journal: Biomed Res Int. 2015;2015:690721.
Title: Increased Expression of Serglycin in Specific Carcinomas and Aggressive Cancer Cell Lines.
Author: Korpetinou, Angeliki|Papachristou, Dionysios J|Lampropoulou, Angeliki|Bouris, Panagiotis|Labropoulou, Vassiliki T|Noulas, Argyrios|Karamanos, Nikos K|Theocharis, Achilleas D
PMID: 26581653
Journal: Cell Physiol Biochem. 2018;48(6):2429-2440.
Title: SRGN Promotes Colorectal Cancer Metastasis as a Critical Downstream Target of HIF-1alpha.
Author: Xu, Yang|Xu, Jie|Yang, Yanfang|Zhu, Lei|Li, Xubin|Zhao, Weipeng
PMID: 30121667